Silvant Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938K | Sell |
8,732
-34,028
| -80% | -$3.65M | 0.04% | 148 |
|
|
2025
Q1 | $4.31M | Hold |
42,760
| – | – | 0.2% | 65 |
|
|
2024
Q4 | $3.82M | Hold |
42,760
| – | – | 0.16% | 80 |
|
|
2024
Q3 | $3.58M | Sell |
42,760
-34,752
| -45% | -$2.91M | 0.16% | 86 |
|
|
2024
Q2 | $5.97M | Hold |
77,512
| – | – | 0.26% | 54 |
|
|
2024
Q1 | $5.31M | Hold |
77,512
| – | – | 0.25% | 62 |
|
|
2023
Q4 | $4.48M | Hold |
77,512
| – | – | 0.24% | 65 |
|
|
2023
Q3 | $4.09M | Hold |
77,512
| – | – | 0.25% | 63 |
|
|
2023
Q2 | $4.19M | Hold |
77,512
| – | – | 0.24% | 72 |
|
|
2023
Q1 | $3.88M | Hold |
77,512
| – | – | 0.25% | 73 |
|
|
2022
Q4 | $3.59M | Sell |
77,512
-803
| -1% | -$37.2K | 0.25% | 78 |
|
|
2022
Q3 | $3.03M | Buy |
+78,315
| New | +$3.03M | 0.21% | 84 |
|